Trials / Active Not Recruiting
Active Not RecruitingNCT07440524
A Phase 2 Trial of JKN24011 in COPD
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Subcutaneous JKN24011 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 215 (actual)
- Sponsor
- Joincare Pharmaceutical Group Industry Co., Ltd · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Subcutaneous JKN24011 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Detailed description
JKN24011 targets TSLP
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | JKN24011 | JKN24011 subcutaneous injection,Q4W |
| OTHER | Placebo | Placebo subcutaneous injection,Q4W |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2026-04-01
- Completion
- 2026-05-01
- First posted
- 2026-02-27
- Last updated
- 2026-02-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07440524. Inclusion in this directory is not an endorsement.